| 000 | 01573 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517171141.0 | ||
| 264 | 0 | _c20190403 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a2287-285X | ||
| 024 | 7 |
_a10.3350/cmh.2016.0087 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShin, Hyun Phil | |
| 245 | 0 | 0 |
_aEfficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function. _h[electronic resource] |
| 260 |
_bClinical and molecular hepatology _c12 2017 |
||
| 300 |
_a316-322 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRenal Insufficiency, Chronic _xcomplications |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSofosbuvir _xadverse effects |
| 650 | 0 | 4 | _aSustained Virologic Response |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPark, Ji-Ae | |
| 700 | 1 | _aBurman, Blaire | |
| 700 | 1 | _aKozarek, Richard A | |
| 700 | 1 | _aSiddique, Asma | |
| 773 | 0 |
_tClinical and molecular hepatology _gvol. 23 _gno. 4 _gp. 316-322 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3350/cmh.2016.0087 _zAvailable from publisher's website |
| 999 |
_c27484635 _d27484635 |
||